Skip to content
STAAStaar Surgical Co

Earnings

When Staar Surgical Co reports, what it reported each quarter, and how the stock took the results.

62 quarters. Jul 2, 2010 to Oct 2, 2026. USD.

Next results · Q4 2026Projected

Mar 2, after the close

Tue, Mar 2, 2027in 104 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Jan 1, 2027
10-K window
Feb 22 – Mar 5

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$57.80M
Revenue, change from a year earlier: Q3 2026 −12.0%, Q2 2026 +111.0%, Q1 2026 +119.6%, Q4 2025 +18.1%
Net income
-$18.31M
Net income, change from a year earlier: Q3 2026 −37.2%, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 −38.9%, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 −10.0%

Quarter by quarter

Q3 2026$83.41M−12.0% vs Q3 2025

Latest results

  1. Q3 2026Nov 4, 2026, after the closeThe release1.7%by the close of Nov 5
    Revenue
    $83.41M
    −12.0%
    Net income
    $5.58M
    −37.2%
    EPS
    $0.11
    −38.9%
    STAAR delivered third-quarter net sales of $83.4 million, a 12% decrease from $94.7 million in the same period last year.
  2. Q2 2026Aug 12, 2026, after the closeThe release0.4%by the close of Aug 13
    Revenue
    $93.54M
    +111.0%
    Net income
    $8.06M
    N/M
    EPS
    $0.16
    N/M
  3. Q1 2026May 13, 2026, after the closeThe release+8.8%by the close of May 14
    Revenue
    $93.52M
    +119.6%
    Net income
    $5.21M
    N/M
    EPS
    $0.10
    N/M
  4. Q4 2025Mar 3, 2026, after the closeThe release+1.7%by the close of Mar 4
    Revenue
    $57.80M
    +18.1%
    Net income
    -$18.31M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Oct 2, 2026Nov 4, 2026 · after-hoursNov 4, 202633 d10-Q$83.41M−12.0%$0.111.7%
Q2 2026Jul 3, 2026Aug 12, 2026 · after-hoursAug 12, 202640 d10-Q$93.54M+111.0%$0.160.4%
Q1 2026Apr 3, 2026May 13, 2026 · after-hoursMay 13, 202640 d10-Q$93.52M+119.6%$0.10+8.8%
FY 2025
Q4 2025derivedJan 2, 2026Mar 3, 2026 · after-hoursMar 3, 202660 d10-K$57.80M+18.1%—+1.7%
Q3 2025Sep 26, 2025Nov 5, 2025 · after-hoursNov 5, 202540 d10-Q$94.73M+6.9%$0.18+5.5%
Q2 2025Jun 27, 2025Aug 6, 2025 · after-hoursAug 6, 202540 d10-Q$44.32M−55.2%-$0.34+0.2%
Q1 2025Mar 28, 2025May 7, 2025 · after-hoursMay 7, 202540 d10-Q$42.59M−44.9%-$1.10+0.2%
FY 2024
Q4 2024derivedDec 27, 2024Feb 11, 2025 · after-hoursFeb 21, 202556 d10-K$48.95M−35.8%—24.7%
Q3 2024Sep 27, 2024Oct 30, 2024 · after-hoursOct 30, 202433 d10-Q$88.59M+10.3%$0.201.7%
Q2 2024Jun 28, 2024Aug 7, 2024 · after-hoursAug 7, 202440 d10-Q$99.01M—$0.15—
Q1 2024Mar 29, 2024May 7, 2024 · after-hoursMay 7, 202439 d10-Q$77.36M—-$0.07—
Earlier years, FY 2010 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 4, 2026000041
10-QAug 12, 2026000037
10-QMay 13, 2026000023
10-KMar 3, 2026000004
10-QNov 5, 2025266879
10-QAug 6, 2025103982
10-QMay 7, 2025065665
10-KFeb 21, 2025024813
10-QOct 30, 2024118973
10-QAug 7, 2024092753

Provenance

ProvenanceData status and checks

Staar Surgical Co · CIK 718937 · Engraved from SEC EDGAR